Trial intelligence / Profile preview

Influence of 5-ASA on Thiopurine Metabolites in IBD

NCT00167882Phase 4Completed

Sponsor
Amsterdam University Medical Center
Start
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Salcrozine in inflammatory bowel disease (IBD), sponsored by Amsterdam University Medical Center. Started Jul 2005; status: completed.

02

Drugs

Salcrozine
03

Conditions

inflammatory bowel disease (IBD)

Beyond the preview

Go deeper on NCT00167882.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00167882.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call